GPR15 and psoriasis: Because effects on dermal lymphocytes might potentially indirectly affect itch and inflammation by producing barrier dysfunction, some of the effects we observed in our studies may have formally arisen through GPR15 particularly in our studies using the imiquimod model of psoriasis (19).